China was the first country to approve a gene therapy product for commercial use, in 2004. The U.S. has yet to endorse any such treatments and the field has been plagued by carcinogenicity
“These two examples of products in the two flavours in which gene therapy is available today – ex-vivo and in-vivo – made it to the final stage, which is great news for the entire field,” he says.
This article is reproduced with permission from the magazine Nature. The article was first published on July 20, 2012.
See what we're tweeting about
DNLee5 For @TheDarkSci A Guide for Scientists on Giving Comments to Journalists http://t.co/fy5vJmnNkM via @ngphenomena @edyong209 #science #NABJ
Horganism Scientists discover evidence of multiverses... Not! http://t.co/X6NbeCIb0C DNLee5 “@DrEscotet: Dreaming of animals and other warning signs of neurodegeneration @Guardian – http://t.co/HjQ9oBhpjH” I have ALL OF THESE issues
Deadline: Jun 30 2013
Reward: $1,000,000 USD
This is a Reduction-to-Practice Challenge that requires written documentation and&
Deadline: Aug 31 2013
Reward: $100,000 USD
The Geoffrey Beene Foundation Alzheimer’s Initiative (GBFAI) is launching the 2013 Geoffrey Beene Global NeuroDiscovery Challenge whose
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
Comments
Add Comment